TP53 and neoplasm: In a KRASG12D -driven PDAC model, loss of p53 promoted tumor progression through increased expression of chemokines, such as CCL3, CCL11, CXCL5, and macrophage colony-stimulating factor (M-CSF), and the accumulation of macrophages and Treg cells within the TME (79).